Delivery Order SPE2DB22D2006-SPE2DB25FW2MA
- Not listed
- The Defense Logistics Agency awarded a $5,450.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 7, 2025, for the supply of IPOL vial 5ML, an inactivated polio vaccine. This competitively awarded, non-set-aside contract represents a routine pharmaceutical procurement supporting military medical supply requirements. The delivery order is scheduled for completion by June 9, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,159.48 to AmerisourceBergen Drug Corp for IPOL Vial 5ML on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. IPOL is an inactivated poliovirus vaccine commonly used in federal immunization programs and military healthcare systems. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,634.20 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of IPOL Vial 5ML, an inactivated polio vaccine product. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, was issued without a set-aside designation, indicating competitive award. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,652.21 to AmerisourceBergen Drug Corp for IPOL vial 5ML, a poliomyelitis vaccine product. The contract, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, is a firm fixed price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a competitive procurement action under an existing contract...
- The Defense Logistics Agency awarded a delivery order valued at $54,368.42 to AmerisourceBergen Drug Corp for the supply of IPOL vial 5ML, a poliomyelitis vaccine product. This firm fixed price, competitively awarded delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $36,690.60 by the Defense Logistics Agency for the supply of Ipol vial 5ml on April 24, 2025, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken facility. Ipol is an inactivated polio vaccine used within...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of IPOL Vial 5ML, a poliomyelitis vaccine product. This firm fixed-price delivery order, valued at $1,526.14, represents a non-competitive award and is categorized as a child contract under AmerisourceBergen's larger federal contract vehicle. The order is scheduled for completion by August 19, 2025, with performance at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $53.6K delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for supply of Ipol Vial 5ML, a polio vaccine product. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 8, 2025, and performance location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999M and extending through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ipol Vial 5ML, a poliomyelitis vaccine product. This firm fixed price delivery order has a ceiling value of $31,302.96 and an ultimate completion date of August 22, 2025, with no set-aside designation. The contract represents a non-competitive award made under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued...
- The Defense Logistics Agency awarded a delivery order valued at $2,180.20 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Ipol Vial 5ML, a polio vaccine product. This is a firm fixed price, non-competitive delivery order with a completion date of May 28, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued under a larger vehicle—AmerisourceBergen's Indefinite Delivery...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW2MADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,090.10 to AmerisourceBergen Drug Corp for 5mL IPOL vials on July 14, 2025, with an ultimate completion date of July 15, 2025. IPOL is an inactivated polio vaccine commonly used by the Department of Defense and other federal healthcare systems for immunization programs. This competitively awarded, non-set-aside contract reflects a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $1 billion comprehensive pharmaceutical support vehicle designated SPE2DX that runs through December 2026. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine transactional purchase under AmerisourceBergen's established IDC vehicle, which serves as a critical supply channel for pharmaceutical and medical products to support military healthcare operations globally. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal procurement portfolio with DLA and other defense health agencies. The company's contract awards demonstrate capability in fulfilling diverse medical supply requirements, including vaccines, medications, and specialized healthcare commodities across multiple therapeutic domains for military personnel and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/14/25 |